NAPP Logo
  • NAPP logo
  • About Us
  • Products
  • Working at Napp
  • Partnering
    • Commercial partnering
    • Joint working
  • Education
    • NAPP Academy
  • Media
    • News
    • Press Releases
  • Contact
  • Home
  • About Us
  • Products
  • Working at Napp
  • Partnering
  • Education
  • Media
  • Contact

Napp Pharmaceuticals Ltd Medicines Information for Non-Healthcare Professionals

This page lists all medicines currently sold by Napp Pharmaceuticals Ltd to the UK NHS. This page is intended for members of the UK public, or UK-based patients being treated with one or more of Napp’s products.

It is important to emphasise that if you (or a family member) are being treated with a Napp product and you have a question or concern about your treatment, it is recommended that you speak to your Healthcare Professional in the first instance, as they will be best-placed to assist you.

Reporting of Side Effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.

Medicines showing a black triangle symbol (▼) are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See yellowcard.mhra.gov.uk for how to report side effects.

The medicines are listed by alphabetical order of the active ingredient. Patient Information Leaflets (PILs) are the most suitable information for patients and public, however you may also review the Summary of Product Characteristics (SmPC) and/or regulatory Assessment Report (AR) if you wish, although both of the document types are primarily intended for Healthcare Professionals.

Due to the UK’s recent exit from the European Union, some medicines now have separate information available for Northern Ireland (NI) and Great Britain (GB), whereas the information for some products is still applicable across the United Kingdom (UK). Please ensure you select the link corresponding to the part of the UK where you are resident.

Medicines marked with an exclamation mark (!) are in the process of being discontinued and may have limited availability. Please speak to your Healthcare Professional if you have any concerns.

UK-INV-2100223

Date of Prep: Aug 2021

Active IngredientBrand NamePatient Information LeafletSummary of Product CharacteristicsRegulatory Assessment Report
BuprenorphineBuTrans® patchesUK: PILUK: BuTrans 5, 10, & 20 SmPC BuTrans 15 SmPCNot available
BuprenorphineTranstec® patchesUK: PILUK: SmPCNot available
CanagliflozinInvokana® tablets GB: PIL NI: SmPC & PILGB: SmPC NI: SmPC & PILEU: AR
Canagliflozin / metforminVokanamet® tabletsGB: PIL NI: SmPC & PILGB: SmPC NI: SmPC & PILEU: AR
Dihydrocodeine tartrateDHC® Continus® tabletsUK: PILUK: SmPCNot available
Diltiazem hydrochlorideAdizem-SR® capsulesUK: PILUK: SmPCNot available
Diltiazem hydrochlorideAdizem-XL® capsulesUK: PILUK: SmPCNot available
Fluticasone propionate, formoterol fumarate dihydrateflutiform® inhalerUK: PILUK: SmPCUK: AR
(!) Fluticasone propionate, formoterol fumarate dihydrateFlutiform® K-haler® inhaler UK: PILUK: SmPCUK: AR
Hydromorphone hydrochloridePalladone® injectionUK: PILUK: SmPCUK: AR
Hydromorphone hydrochloridePalladone® capsulesUK: PILUK: SmPCNot available
Hydromorphone hydrochloridePalladone® SR capsulesUK: PILUK: SmPCNot available
Morphine sulfateMST® Continus® tabletsUK: PILUK: SmPCNot available
(!) Morphine sulfateMST® Continus® sachetsUK: PILUK: SmPCNot available
Morphine sulfateMXL® capsulesUK: PILUK: SmPCNot available
Morphine sulfateSevredol® tabletsUK: PILUK: SmPCNot available
Naloxone hydrochloride dihydrateNyxoid® nasal sprayUK: Training Card; Patient Information Card; Training Video NI: SmPC & PILGB: SmPC UK: Healthcare Professional Guidance Document NI: SmPC & PILEU : AR
Oxycodone hydrochlorideOxyContin® tabletsUK: PILUK: SmPCUK: AR
Oxycodone hydrochlorideOxyNorm® capsulesUK: PILUK: SmPCNot available
Oxycodone hydrochlorideOxyNorm® injectionUK: PIL10 mg/ml UK: SmPC 50 mg/ml UK: SmPC10 mg/ml - Not available 50 mg/ml - UK: AR
Oxycodone hydrochlorideOxyNorm® liquid and OxyNorm® concentrateUK: PILUK: SmPCNot available
Oxycodone hydrochloride / naloxone hydrochloride dihydrateTarginact® tabletsUK: PILUK: SmPCNot available
▼PegfilgrastimPelmeg® injectionGB: PIL NI: SmPC & PILGB: SmPC NI: SmPC & PILEU: AR
▼ RituximabTruxima® injectionGB: PIL NI: PIL UK: Patient Alert Card; Patient Information NI: SmPC & PILGB: SmPC UK: Administration Route; Safety Sheet NI: SmPC & PILEU: AR
TheophyllineUniphyllin® Continus® tabletsUK: PILUK: SmPCNot available
▼ Trastuzumab Herzuma® injectionGB: PIL NI: SmPC & PILGB: SmPC NI: SmPC & PILEU: AR

Stay connected

  • Legal
  • Cookie Policy
  • Privacy Notice
  • Registered Company
  • Modern Slavery Statement
  • Integrity Line
  • Tax Strategy
  • Group Pension Scheme
  • PENSION IMPLEMENTATION STATEMENT
  • Statement of Investment Principles
© 2022 NAPP Pharmaceuticals Limited. DATE OF PREP: AUG 2021 UK-INV-2100223

You are now leaving our website. Napp does not accept any responsibility for the third party site.

Please click "Continue to external link" if you want to proceed.

Go Back
Continue to external link

This website uses cookies so that we can provide you with the best user experience possible.

 

Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

 

We use necessary cookies to ensure the proper functioning of our site.

 

We'd also like to set optional analytics cookies to help us to improve your experience when using the site. We won't set optional cookies unless you choose to enable them. Using this tool will place a cookie on your device which will remember your preferences when you next visit.

 

For more detailed information about the cookies we use, please refer to our Cookie Policy. Settings.

Napp
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy